<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37893865</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2790</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare11202790</ELocationID><Abstract><AbstractText>COVID-19 infection adversely impacts patients' wellbeing and daily lives. This survey-based study examined differences in patient-reported COVID-19 symptoms, Health-Related Quality of Life (HRQoL) and Work Productivity and Activity Impairment (WPAI) among groups of patients defined based on age and symptom-based long COVID status. Symptomatic, COVID-19-positive US outpatients were recruited from 31 January-30 April 2022. Outcomes were collected via validated instruments at pre-COVID, Day 3, Week 1, Week 4, Month 3 and Month 6 following infection, with changes assessed from pre-COVID and between groups, adjusting for covariates. EQ-5D-5L HRQoL and WPAI scores declined in all groups, especially during the first week. Long COVID patients reported significantly higher symptoms burden and larger drops in HRQoL and WPAI scores than patients without long COVID. Their HRQoL and WPAI scores did not return to levels comparable to pre-COVID through Month 6, except for absenteeism. Patients without long COVID generally recovered between Week 4 and Month 3. Older (&gt;50) and younger adults generally reported comparable symptoms burden and drops in HRQoL and WPAI scores. During the first week of infection, COVID-19-related health issues caused loss of 14 to 26 work hours across the groups. These data further knowledge regarding the differential impacts of COVID-19 on clinically relevant patient groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Fusco</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0079-7331</Identifier><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelleri</LastName><ForeName>Joseph C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anatale-Tardiff</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CVS Health, Woonsocket, RI 02895, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coetzer</LastName><ForeName>Henriette</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0009-7093-9279</Identifier><AffiliationInfo><Affiliation>CVS Health, Woonsocket, RI 02895, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yehoshua</LastName><ForeName>Alon</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Mary B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Kristen E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porter</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0009-0005-5089-2873</Identifier><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puzniak</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cha-Silva</LastName><ForeName>Ashley S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-8484-6251</Identifier><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Santiago M C</ForeName><Initials>SMC</Initials><AffiliationInfo><Affiliation>Pfizer Inc., New York, NY 10001, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiaowu</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-7960-4207</Identifier><AffiliationInfo><Affiliation>CVS Health, Woonsocket, RI 02895, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">economic</Keyword><Keyword MajorTopicYN="N">humanistic</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>M.D.F., J.C.C., A.Y., M.B.A., K.A., T.M.P., L.P., A.S.C.-S. and S.M.C.L. are employees of Pfizer, Inc. and hold stock and/or stock options of Pfizer, Inc. X.S. is an employee of CVS Health and holds stock of CVS Health. L.A.-T. and H.C. were employees of CVS Health when the study was conducted and are now employees of Blue Health Intelligence (BHI), the trade name of Health Intelligence Company, LLC, an independent licensee of the Blue Cross Blue Shield Association. The sponsor had no further involvement beyond the author contributions declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37893865</ArticleId><ArticleId IdType="pmc">PMC10606451</ArticleId><ArticleId IdType="doi">10.3390/healthcare11202790</ArticleId><ArticleId IdType="pii">healthcare11202790</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention  Long COVID or Post-COVID Conditions.  [(accessed on 5 May 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Poudel A.N., Zhu S., Cooper N., Roderick P., Alwan N., Tarrant C., Ziauddeen N., Yao G.L. Impact of Covid-19 on health-related quality of life of patients: A structured review. PLoS ONE. 2021;16:e0259164. doi: 10.1371/journal.pone.0259164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259164</ArticleId><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J. Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez D.C., Normand K., Zhaoyun Y., Torres-Castro R. Long-term impact of COVID-19: A systematic review of the literature and meta-analysis. Biomedicines. 2021;9:900. doi: 10.3390/biomedicines9080900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080900</ArticleId><ArticleId IdType="pmc">PMC8389585</ArticleId><ArticleId IdType="pubmed">34440104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N.D., Slaughter D., Edwards D., Dalton A., Perrine C., Vahratian A., Saydah S. Long COVID and Significant Activity Limitation Among Adults, by Age&#x2014;United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:866&#x2013;870. doi: 10.15585/mmwr.mm7232a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fusco M., Sun X., Moran M.M., Coetzer H., Zamparo J.M., Alvarez M.B., Puzniak L., Tabak Y.P., Cappelleri J.C. Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron. J. Patient-Rep. Outcomes. 2023;7:77. doi: 10.1186/s41687-023-00616-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-023-00616-5</ArticleId><ArticleId IdType="pmc">PMC10366033</ArticleId><ArticleId IdType="pubmed">37486567</ArticleId></ArticleIdList></Reference><Reference><Citation>Brus I.M., Spronk I., Haagsma J.A., de Groot A., Tieleman P., Biere-Rafi S., Polinder S. The prolonged impact of COVID-19 on symptoms, health-related quality of life, fatigue and mental well-being: A cross-sectional study. Front. Epidemiol. 2023;3:1144707. doi: 10.3389/fepid.2023.1144707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fepid.2023.1144707</ArticleId><ArticleId IdType="pmc">PMC10911032</ArticleId><ArticleId IdType="pubmed">38455946</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony L., Buwalda T., Blair M., Forde B., Lunjani N., Ambikan A., Neogi U., Barrett P., Geary E., O&#x2019;Connor N., et al. Impact of Long COVID on health and quality of life. HRB Open Res. 2022;5:31. doi: 10.12688/hrbopenres.13516.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/hrbopenres.13516.1</ArticleId><ArticleId IdType="pmc">PMC9440374</ArticleId><ArticleId IdType="pubmed">36101871</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab-Zozani M., Hashemi F., Safari H., Yousefi M., Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res. Perspect. 2020;11:296. doi: 10.24171/j.phrp.2020.11.5.05.</Citation><ArticleIdList><ArticleId IdType="doi">10.24171/j.phrp.2020.11.5.05</ArticleId><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandasena H., Pathirathna M., Atapattu A., Prasanga P. Quality of life of COVID 19 patients after discharge: Systematic review. PLoS ONE. 2022;17:e0263941. doi: 10.1371/journal.pone.0263941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263941</ArticleId><ArticleId IdType="pmc">PMC8849513</ArticleId><ArticleId IdType="pubmed">35171956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanguay P., D&#xe9;cary S., Lemaire-Paquette S., L&#xe9;onard G., Pich&#xe9; A., Dubois M.-F., Kairy D., Bravo G., Corriveau H., Marquis N. Trajectories of health-related quality of life and their predictors in adult COVID-19 survivors: A longitudinal analysis of the Biobanque Qu&#xe9;b&#xe9;coise de la COVID-19 (BQC-19) Qual. Life Res. 2023;32:2707&#x2013;2717. doi: 10.1007/s11136-023-03406-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-023-03406-0</ArticleId><ArticleId IdType="pmc">PMC10066943</ArticleId><ArticleId IdType="pubmed">37004627</ArticleId></ArticleIdList></Reference><Reference><Citation>Moens M., Duarte R.V., De Smedt A., Putman K., Callens J., Billot M., Roulaud M., Rigoard P., Goudman L. Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients. Front. Public Health. 2022;10:991572. doi: 10.3389/fpubh.2022.991572.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.991572</ArticleId><ArticleId IdType="pmc">PMC9632164</ArticleId><ArticleId IdType="pubmed">36339175</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona V., Kirouchena D., Clerc P., Pinsard-Laventure F., Bourrion B. Quality of life in COVID-19 outpatients: A long-term follow-up study. J. Clin. Med. 2022;11:6478. doi: 10.3390/jcm11216478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11216478</ArticleId><ArticleId IdType="pmc">PMC9657247</ArticleId><ArticleId IdType="pubmed">36362706</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuzuki S., Miyazato Y., Terada M., Morioka S., Ohmagari N., Beutels P. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health Qual. Life Outcomes. 2022;20:125. doi: 10.1186/s12955-022-02033-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-022-02033-6</ArticleId><ArticleId IdType="pmc">PMC9388960</ArticleId><ArticleId IdType="pubmed">35986269</ArticleId></ArticleIdList></Reference><Reference><Citation>Landry M., Bornstein S., Nagaraj N., Sardon Jr G.A., Castel A., Vyas A., McDonnell K., Agneshwar M., Wilkinson A., Goldman L. Postacute Sequelae of SARS-CoV-2 in University Setting. Emerg. Infect. Dis. 2023;29:519. doi: 10.3201/eid2903.221522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2903.221522</ArticleId><ArticleId IdType="pmc">PMC9973677</ArticleId><ArticleId IdType="pubmed">36703253</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis R.H., Santillana M., Ognyanova K., Safarpour A., Trujillo K.L., Simonson M.D., Green J., Quintana A., Druckman J., Baum M.A. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatz E.S., Gottlieb M., Wisk L.E., Anderson J., Chang A.M., Gentile N.L., Hill M.J., Huebinger R.M., Idris A.H., Kinsman J. Three-Month Symptom Profiles among Symptomatic Adults with Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Tests: A Prospective Cohort Study From the INSPIRE Group. Clin. Infect. Dis. 2022;76:1559&#x2013;1566. doi: 10.1093/cid/ciac966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac966</ArticleId><ArticleId IdType="pmc">PMC11361781</ArticleId><ArticleId IdType="pubmed">36573005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M., Wang R., Yu H., Spatz E.S., Montoy J.C., Rodriguez R., Chang A.M., Elmore J.G., Hannikainen P.A., Hill M. Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections during the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study. Clin. Infect. Dis. 2023;76:1930&#x2013;1941. doi: 10.1093/cid/ciad045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad045</ArticleId><ArticleId IdType="pmc">PMC10249989</ArticleId><ArticleId IdType="pubmed">36705268</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol Research Foundation  EQ-5D-5L User Guide, Version 3.0.  [(accessed on 22 August 2023)].  Available online:  https://euroqol.org/publications/user-guides.</Citation></Reference><Reference><Citation>Di Fusco M., Sun X., Moran M.M., Coetzer H., Zamparo J.M., Puzniak L., Alvarez M.B., Tabak Y.P., Cappelleri J.C. Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: Quality of life, symptoms, and work productivity among US adult outpatients. J. Patient-Rep. Outcomes. 2022;6:123. doi: 10.1186/s41687-022-00528-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-022-00528-w</ArticleId><ArticleId IdType="pmc">PMC9722994</ArticleId><ArticleId IdType="pubmed">36469198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickard A.S., Law E.H., Jiang R., Pullenayegum E., Shaw J.W., Xie F., Oppe M., Boye K.S., Chapman R.H., Gong C.L., et al. United States Valuation of EQ-5D-5L Health States Using an International Protocol. Value Health. 2019;22:931&#x2013;941. doi: 10.1016/j.jval.2019.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2019.02.009</ArticleId><ArticleId IdType="pubmed">31426935</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353&#x2013;365. doi: 10.2165/00019053-199304050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-199304050-00006</ArticleId><ArticleId IdType="pubmed">10146874</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly Associates  WPAI Scoring.  [(accessed on 9 September 2023)].  Available online:  http://www.reillyassociates.net/WPAI_Scoring.html.</Citation></Reference><Reference><Citation>Rosner B. Fundamentals of Biostatistics. 8th ed. Cengage Learning; Boston, MA, USA: 2015.</Citation></Reference><Reference><Citation>Freeman G., Halton J.H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika. 1951;38:141&#x2013;149. doi: 10.1093/biomet/38.1-2.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/38.1-2.141</ArticleId><ArticleId IdType="pubmed">14848119</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzmaurice G.M., Laird N.M., Ware J.H. Applied Longitudinal Analysis. 2nd ed. Volume 998 John Wiley &amp; Sons; Hoboken, NJ, USA: 2011.</Citation></Reference><Reference><Citation>Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum Associates; Hillsdale, NJ, USA: 1988.</Citation></Reference><Reference><Citation>McLeod L.D., Cappelleri J.C., Hays R.D. Best (but oft-forgotten) practices: Expressing and interpreting associations and effect sizes in clinical outcome assessments. Am. J. Clin. Nutr. 2016;103:685&#x2013;693. doi: 10.3945/ajcn.115.120378. Erratum in Am. J. Clin. Nutr. 2017, 2105, 2241, doi:10.3945/ajcn.116.148593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.120378</ArticleId><ArticleId IdType="pmc">PMC4763495</ArticleId><ArticleId IdType="pubmed">26864358</ArticleId></ArticleIdList></Reference><Reference><Citation>STROBE Statement&#x2014;Checklist of Items That Should Be Included in Reports of Cohort Studies.  [(accessed on 9 September 2023)].  Available online:  https://www.strobe-statement.org/download/strobe-checklist-cohort-studies-pdf.</Citation></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P., De Pauw R., Van Cauteren D., Demarest S., Drieskens S., Cornelissen L., Devleesschauwer B., De Ridder K., Charafeddine R. Post COVID-19 condition and health-related quality of life: A longitudinal cohort study in the Belgian adult population. BMC Public Health. 2023;23:1433. doi: 10.1186/s12889-023-16336-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-16336-w</ArticleId><ArticleId IdType="pmc">PMC10373376</ArticleId><ArticleId IdType="pubmed">37495947</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>